Evidence map›Paper›PMID 20661667›Full record

ArticleMedical oncology (Northwood, London, England)2011

Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.

Patricia Piña-Sánchez, Dulce María Hernández-Hernández, Lucia Taja-Chayeb, Ricardo M Cerda-Flores, Ana Lilia González-Herrera, Carlos Rodea-Avila, Teresa Apresa-García, Patricia Ostrosky-Wegman, Guelaguetza Vázquez-Ortíz, Patricia Mendoza-Lorenzo and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Association between theFrontiers in oncology · 2025
    Pooled it
  2. Article
  3. Review
  4. Polymorphism Located in the Upstream Region of theJournal of cancer prevention · 2018
    Article
  5. Oncology letters · 2018
    Article
  6. Article
  7. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Patricia Piña-SánchezOncology Genomic Laboratory, Oncology Research Unit, Oncology Hospital, National Medical Center SXXI-IMSS, Av. Cuauhtemoc 330, Col. Doctores, 06720, Delegación Cuauhtemoc, DF, Mexico.
Dulce María Hernández-Hernández
Lucia Taja-Chayeb
Ricardo M Cerda-Flores
Ana Lilia González-Herrera
Carlos Rodea-Avila
Teresa Apresa-García
Patricia Ostrosky-Wegman
Guelaguetza Vázquez-Ortíz
Patricia Mendoza-Lorenzo
Alfonso Dueñas-González
Mauricio Salcedo
Mexican Social Security Institute · MXInstituto Nacional de Cancerología · MXUniversidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer (CC) is the second most common cancer in Mexican women. Human papillomavirus (HPV) infection is necessary but not sufficient for CC development. Furthermore, genetic factors as polymorphisms could be important susceptibility factors. Controversial results regarding TP53 polymorphisms specifically in codon 72 of CC have been reported. In the present work, the exon 4 sequence of TP53 gene in CC and healthy Mexican-mestizo women were analyzed. A group of 111 women with CC and 126 healthy women (control) were included. Peripheral blood cells for polymorphism analysis and cervical scrape for HPV detection were used. PCR of exon 4 of TP53 were subjected to denaturing high-performance liquid chromatography (DHPLC) analysis and sequencing. HPV detection was subjected to PCR and sequencing. The statistical analysis was carried out using the Arlequin software. Codon 72 Arg/Arg was the most common SNP detected, and Hardy-Weinberg analysis showed equilibrium in control and CC samples (P>0.05). Wild type sequence of TP53 exon 4 was detected in 66 and 57% in control and CC samples, respectively. For codon 72 Arg/Arg, differences between control and CC women were found (P=0.043). An association between HPV 16/18 infection and 72 Arg/Arg in woman with CC was found (P=0.026). Haplotype GC (codon 36 and 72) was statistically significantly associated with CC (P=0.011). HPV 16 was the most common viral type. Codon 72 Arg/Arg is the most common polymorphism in the Mexican population and could be associated to HPV 16 and/or HPV 18 infection in CC.

Indexed as

Polymorphism, Single NucleotideAdultBase SequenceChromatography, High Pressure LiquidExonsFemaleGenetic Predisposition to DiseaseGenotypeHaplotypesHuman papillomavirus 16Human papillomavirus 18HumansMexicoMiddle AgedNeoplasm StagingPapillomavirus InfectionsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID20661667
OpenAlexW2117051177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.